* Proof of higher returns needed to maintain turnaround

PARENT-ONLY EARNINGS ESTIMATES
(in billions of yen unless specified)

PARENT-ONLY EARNINGS ESTIMATES
(in billions of yen unless specified)

* Daiichi says not known when export ban will be lifted

TOKYO, Sept 3 (Reuters) - Daiichi Sankyo , Japan's
No.3 drugmaker, said on Friday it believes it has made progress
towards lifting a U.S. ban on exports from Ranbaxy Laboratories'
two plants in India.

SYDNEY, Sept 3 (Reuters) - Australia's Sigma
Pharmaceuticals said on Friday it has been advised of
a possible shareholder class action relating to alleged
non-disclosure over a Sept 2009 capital raising.

NEW YORK, Sept 2 (Reuters) - Drugmaker Abbott Laboratories
has decided against the sale of its European
flu-vaccine business after initial bids came in below its
expectations, a company spokeswoman confirmed.

* Study is first to find gullet cancer link to long-term use

Sept 2 (Reuters) - Eye-care company Cooper Cos Inc
posted a better-than-expected quarterly profit as it gained
market share in its contact lens and surgical businesses, and
the company raised its full-year forecast, sending its shares
up 4 percent after market.

* Nearly $361 million in ceftaroline sales seen in 2014
(Revises first sentence, adds analyst comment, updates
shares)